Literature DB >> 23188559

Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells.

Zhipin Liang1, Zhiyuan Guo, Xin Wang, Xiaohong Kong, Chang Liu.   

Abstract

The cellular protein tetherin tethers the HIV-1 viral particles on the cellular membrane to inhibit the replication of HIV-1. However, the HIV-1 accessory protein Vpu counteracts the antiviral function of tetherin. In this study, two retroviral vector plasmids were constructed. One inhibited the vpu gene expression; the other one over-expressed the tetherin. Both retroviral vector plasmids could be packaged in the packaging cell line PT67 to obtain the corresponding retroviruses. The retroviral vector plasmids' functions of tetherin over-expression or vpu-RNAi were detected at the cell level. Retroviral vector plasmids were transfected to PT67 cells at different ratios from 0T3V to 3T0V, and then mixed retroviruses were harvested. The antiviral functions of mixed retroviruses were detected in HIV-1 infected TZM-bl cells. The results showed that packaged mixed retroviruses could repress the replication of HIV-1 in TZM-bl cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188559      PMCID: PMC8218129          DOI: 10.1007/s12250-012-3263-8

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  21 in total

1.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Authors:  Michael H Malim; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

3.  Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry.

Authors:  A D Miller; F Chen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

5.  HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.

Authors:  Heiko Hauser; Lisa A Lopez; Su Jung Yang; Jill E Oldenburg; Colin M Exline; John C Guatelli; Paula M Cannon
Journal:  Retrovirology       Date:  2010-06-07       Impact factor: 4.602

6.  A novel membrane antigen selectively expressed on terminally differentiated human B cells.

Authors:  T Goto; S J Kennel; M Abe; M Takishita; M Kosaka; A Solomon; S Saito
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

7.  Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.

Authors:  Emily J Platt; Miroslawa Bilska; Susan L Kozak; David Kabat; David C Montefiori
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

8.  ISG15 expression in response to double-stranded RNA or LPS in cultured Fetal bovine lung (FBL) cells.

Authors:  C Liu; R Chang; X Yao; W T Qiao; Y Q Geng
Journal:  Vet Res Commun       Date:  2009-04-15       Impact factor: 2.459

Review 9.  Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.

Authors:  Anna Le Tortorec; Suzanne Willey; Stuart J D Neil
Journal:  Viruses       Date:  2011-05-06       Impact factor: 5.048

10.  siVirus: web-based antiviral siRNA design software for highly divergent viral sequences.

Authors:  Yuki Naito; Kumiko Ui-Tei; Toru Nishikawa; Yutaka Takebe; Kaoru Saigo
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  1 in total

1.  Efficacy Analysis of Combinatorial siRNAs against HIV Derived from One Double Hairpin RNA Precursor.

Authors:  Chang Liu; Zhipin Liang; Xiaohong Kong
Journal:  Front Microbiol       Date:  2017-08-29       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.